Bo-Jung Chen

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Cisplatin-Induced Rab27A/B Exosomal PD-L1 Axis Suppresses Antitumor Immunity and Correlates with Poor 5-Year Survival in Lung Squamous Cell Carcinoma and Adenocarcinoma.

|Dec 22, 2025
Integrated genetic analyses identified T-cell neoplasms other than adult T-cell leukemia/lymphoma in HTLV-1 carriers.

Yu Naito, Takahiko Yasuda, Shugo Sakihama

|Nov 11, 2022
Human Papillomavirus Oncoproteins Confer Sensitivity to Cisplatin by Interfering with Epidermal Growth Factor Receptor Nuclear Trafficking Related to More Favorable Clinical Survival Outcomes in Non-Small Cell Lung Cancer.

Jinn-Li Wang, Wei-Jiunn Lee, Chia-Lang Fang

|Mar 25, 2022
Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV.

Chih-Yi Liu, Bo-Jung Chen, Shih-Sung Chuang

Pageof 1

Frequent Collaborators

2 joint publications

Shih-Sung Sung Chuang

1 joint publications

Yu Naito

1 joint publications

Takahiko Yasuda

1 joint publications

Masayuki Aiba